Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics?

Journal of Burn Care and Research

Volumn 30, Issue 1, 2009, Pages 19-29

  Neely, Alice N ^a   Gardner, Jason ^a   Durkee, Paula ^a   Warden, Glenn D ^b   Greenhalgh, David G ^c   Gallagher, James J ^d   Herndon, David N ^d   Tompkins, Ronald G ^e   Kagan, Richard J ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b Warden Bioscience Associates   (United States)

^c SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

^d SHRINERS HOSPITALS FOR CHILDREN   (United States)

^e SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; HYPOCHLORITE SODIUM; MAFENIDE ACETATE; NEOMYCIN; NYSTATIN; POLYMYXIN; POLYMYXIN B; SILVER NITRATE; SULFADIAZINE SILVER;

ACINETOBACTER; ANTIMICROBIAL ACTIVITY; ARTICLE; BURN; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; ENTEROCOCCUS; KLEBSIELLA; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS; STAPHYLOCOCCUS;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; BACTERIA; BURNS; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; WOUND INFECTION;

EID: 59449086737     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3181921eed     Document Type: Article

References (40)

1. Latenser BA, Miller SF, Bessey PQ, et al. National Burn Repository 2006: a ten-year review. J Burn Care Res 2007;28: 635-8.
2. Dakin HD. The antiseptic action of hypochlorites: the ancient history of the "new antiseptic." BMJ 1915;2:809-10.
3. Klasen HJ. Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 2000;26:117-30.
4. Brock TD. Milestones in microbiology. Washington, DC: ASM Press; 1999. p. 195-9.
5. Siegel JD, Rhinehart E, Jackson M, et al. Management of multidrug-resistant organisms in healthcare settings. Atlanta, GA: Centers for Disease Control and Prevention, 2006; available from www.cdc.gov/ncidod/dhqp/ pdf/ar/MDROGuideline2006.pdf. Accessed December 4, 2008.
6. Siegal JD, Rhinehart E, Jackson M, et al. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Atlanta, GA: Centers for Disease Control and Prevention, 2007; available from www.cdc.gov/nicdod/dhqp/pdf/guidelines/Isolation2007.pdf. Accessed December 4, 2008.
7. Arnow PM, Allyn PA, Nichols EM, Hill DL, Pezzlo M, Bartlett RH. Control of methicillin-resistant Staphylococcus aureusin a burn unit: role of nurse staffing. J Trauma 1982;22: 954-9.
8. Rutala WA, Katz EB, Sherertz RJ, Sarubbi FA Jr. Environmental study of a methicillin-resistant Staphylococcus aureus epidemic in a burn unit. J Clin Microbiol 1983;18:683-8.
9. Phillips LG, Heggers JP, Robson MC. Burn and trauma units as sources of methicillin resistant Staphylococcus aureus. J Burn Care Rehabil 1992;13:293-7.
10. Sheridan RL, Weber J, Benjamin J, Pasternack MS, Tompkins RG. Control of methicillin-resistant Staphylococcus aureusin a pediatric burn unit. Am J Infect Control 1994;22:340-5.
11. Matsumura H, Yoshizawa N, Narumi A, Harunari N, Sug-amata A, Watanabe K. Effective control of methicillinresistant Staphylococcus aureusin a burn unit. Burns 1996;22: 283-6.
12. Cook N. Methicillin-resistant Staphylococcus aureus versus the burn patient. Burns 1998;24:91-8.
13. Al-Haddad AM, Udo EE, Mokadas EM, Sanyal SC, Grubb WB. Persistence of a clone of methicillin-resistant Staphylococcus aureus in a burns unit. J Med Microbiol 2001;50: 558-64.
14. Embil JM, Mclxod JA, Al-Barrak AM, et al. An outbreak of methicillin resistant Staphylococcus aureus on a burn unit: potential role of contaminated hydrotherapy equipment. Burns 2001;27:681-8.
15. Safdar N, Marx J, Meyer NA, Maki DG. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureusin a burn unit. Am J Infect Control 2006;34:476-83.
16. Min SS, Weber DJ, Donovan BJ, et al. Multidrug-resistant Enterococcus faecium in patient with burns. Clin Infect Dis 2003;36:1210-1.
17. Richard P, LeFloch R, Chamoux C, Pannier M, Espaze E, Richet H. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 1994;170:377-83.
18. Hsueh PR, Teng LJ, Yang PC, Chen YC, Ho SW, Luh KT. Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit. J Clin Microbiol 1998; 36:1347-51.
19. Ozhurt Z, Ertek M, Erol S, Altoparlak U, Akcay MN. The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit. Burns 2005;31:870-3.
20. Simor AE, Lee M, Vearncombe M, et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 2002;23:261-7.
21. Bayat A, Shaaban H, Dodgson A, Dunn KW. Implications for
22. burns unit design following outbreak of multi-resistant Acinetobacter infection in ICU and burn unit. Burns 2003;29:303-6.
23. Ferreira ACB, Gobara S, Costa SF, et al. Emergence of resistance in Pseudomonas aeruginosa and Acinetobacter species after the use of antimicrobials for burned patients. Infect Control Hosp Epidemiol 2004;25:868-72.
24. Tsai W, Chen C, Ko W, Pan SC. Stenotrophomonas maltophilia bacteremia in burn patients. Burns 2006;32:155-8.
25. Kienzle N, Muller M, Pegg S. Chryseobacterium in burn wounds. Burns 2001;27:179-82.
26. Heggers JP, Sazy JA, Stenberg BD, et al. Bactericidal and wound-healing properties of sodium hypochlorite solutions: the 1991 Lindberg Award. J Burn Care Rehabil 1991;12: 420-4.
27. Holder IA, Boyce ST. Formulation of idealized topical antimicrobial mixtures for use with cultured skin grafts. J Antimicrob Chemother 1996;38:457-63.
28. Nathan P, Law EJ, Murphy DF, et al. A laboratory method for selection of topical antimicrobial agents to treat infected burn wounds. Burns 1978;4:177-87.
29. Strock LL, Lee MM, Rutan RL, et al. Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant Staphylococci. J Burn Care Rehabil 1990; 11:454-59.
30. Holder IA, Neely AN. Does the addition of nystatin to 5% mafenide acetate and genitourinary irrigant solutions interfere with their antimicrobial activity? Assessment by two topical antimicrobial test assay systems. J Burn Care Rehabil 2001;22:282-87.
31. Smoot EC, Kucan JO, Graham DR, Barenfanger JE. Susceptibility testing of topical anribacterials against methicillin-resistant Staphylococcus aureus. J Burn Care Rehabil 1992;13: 198-202.
32. Taddonio TE, Thomson PD, Smith DJ Jr, Prasad JK. Topical antimicrobial testing of burn wound microorganisms: evaluation of a new technique. Burns 1990;16:64-66.
33. Heggers JP, Velanovich V, Robson MC, et al. Control of burn wound sepsis: a comparison of in vitro topical antimicrobial assays. J Trauma 1987;27:176-79.
34. Thomson PD, Taddonio TE, Tait MJ, Prasad JK. Susceptibility of Pseudomonas and Staphylococcus wound isolates to topical antimicrobial agents: a 10-year review and clinical evaluation. Burns 1989;15:190-92.
35. McDonald LC. Trends in antimicrobial resistance in health care- associated pathogens and effect on treatment. Clin Infect Dis 2006;42:S65-71.
36. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004. Am J Infect Control 2004;32:470-85.
37. Demling RH, Waterhouse B. The increasing problem of wound bacterial burden and infection in acute and chronic soft-tissue wounds caused by methicillin-resistant Staphylococcus aureus. J Burns Wounds 2007;7:86-98.
38. Walton MA, Carino E, Herndon DN, Heggers JP. The efficacy of polysporin first aid antibiotic spray (polymyxin B sulfate and bacitracin zinc) against clinical burn wound isolates. J Burn Care Rehabil 1991;12:116-9.
39. Holder IA, Boyce ST. Agar well diffusion assay testing of bacterial susceptibility to various antimicrobials in concentrations non-toxic for human cells in culture. Burns 1994;20: 426-29.
40. Herman RA, Rosenquist MD, Chang P. The efficacy of combining 0.5% mafenide acetate suspension and nystatin as a broad spectrum topical burn wound antimicrobial. J Burn Care Rehabil 1999;20:S233; abstract 192.